Anthony Y. Sun - 03 Jan 2022 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Signature
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Anthony Y. Sun
Issuer symbol
ZNTL
Transactions as of
03 Jan 2022
Net transactions value
-$1,662,308
Form type
4
Filing time
05 Jan 2022, 16:49:49 UTC
Previous filing
07 Dec 2021
Next filing
03 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Gift $0 -15,000 -1.2% $0.000000 1,213,659 16 Dec 2021 Direct
transaction ZNTL Common Stock Sale $201,362 -2,573 -0.21% $78.26 1,211,086 03 Jan 2022 Direct F1, F2
transaction ZNTL Common Stock Sale $89,083 -1,125 -0.09% $79.18 1,209,961 03 Jan 2022 Direct F1, F3
transaction ZNTL Common Stock Sale $351,319 -4,372 -0.36% $80.36 1,205,589 03 Jan 2022 Direct F1, F4
transaction ZNTL Common Stock Sale $89,902 -1,108 -0.09% $81.14 1,204,481 03 Jan 2022 Direct F1, F5
transaction ZNTL Common Stock Sale $81,604 -993 -0.08% $82.18 1,203,488 03 Jan 2022 Direct F1, F6
transaction ZNTL Common Stock Sale $25,168 -300 -0.02% $83.89 1,203,188 03 Jan 2022 Direct F1, F7
transaction ZNTL Common Stock Sale $155,425 -2,000 -0.17% $77.71 1,201,188 04 Jan 2022 Direct F1, F8
transaction ZNTL Common Stock Sale $541,140 -6,871 -0.57% $78.76 1,194,317 04 Jan 2022 Direct F1, F9
transaction ZNTL Common Stock Sale $123,767 -1,556 -0.13% $79.54 1,192,761 04 Jan 2022 Direct F1, F10
transaction ZNTL Common Stock Sale $3,539 -44 -0% $80.43 1,192,717 04 Jan 2022 Direct F1, F11
holding ZNTL Common Stock 103,650 03 Jan 2022 By Spouse
holding ZNTL Common Stock 974,302 03 Jan 2022 By Essex Group International, LLC
holding ZNTL Common Stock 213,600 03 Jan 2022 By Hao Bao Zi Trust LLC F12
holding ZNTL Common Stock 125,000 03 Jan 2022 By Hao Jiao Zi Trust LLC F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $77.72 to $78.71. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $78.73 to $79.72. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $79.78 to $80.74. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $80.79 to $81.40. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $81.91 to $82.73. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $83.34 to $84.17. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $77.23 to $78.14. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $78.24 to $79.23. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $79.26 to $80.13. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $80.35 to $80.725. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F12 Represents shares nominally held by Hao Bao Zi Trust LLC on behalf of the Hao Bao Zi Trust (the "Trust"), the sole member of Hao Bao Zi Trust LLC. The Reporting Person's spouse is the investment adviser with sole power to make investment decisions regarding the securities held by the Trust. The Reporting Person disclaims beneficial ownership of the securities held by Hao Bao Zi Trust LLC except to the extent of his pecuniary interest therein, if any.
F13 Represents shares nominally held by Hao Jiao Zi Trust LLC on behalf of the Hao Jiao Zi Trust (the "Trust"), the sole member of Hao Jiao Zi Trust LLC. The Reporting Person's spouse is the investment adviser with sole power to make investment decisions regarding the securities held by the Trust. The Reporting Person disclaims beneficial ownership of the securities held by Hao Jiao Zi Trust LLC except to the extent of his pecuniary interest therein, if any.